Global hepatitis C elimination: history, evolution, revolutionary changes and barriers to overcome

Vol. 61 No. 3, 2020

ROMANIAN JOURNAL of MORPHOLOGY and EMBRYOLOGY

Carmen Nicoleta Oancea, Anca Elena Butaru, Costin Teodor Streba, Daniel Pirici, Ion Rogoveanu, Mihai Mircea Diculescu, Dan Ionut Gheonea

The fundamental discovery of the hepatitis C virus (HCV) in 1989 has led to winning this year s Nobel Prize in Medicine. This achievement guided all the steps in identifying the elements of the virus, in order to develop the treatment and to increase the screening solutions, which have slowed the exposure to the virus. The management of infection started with interferon-alpha (IFN-alpha), which has later enhanced by adding Ribavirin. Nowadays, HCV treatment is based on direct-acting antiviral agents (DAAs). Currently, HCV infection benefits of curative treatment, with which most patients can be cured. When speaking about hepatitis C future, we can say it is looking bright, considering all the progress that has been made in recent years and all the options that we have for curing all genotypes of HCV infection. The aim of this review is to sum up the historical characteristics of HCV discovery, the evolution of treatment and screening actions, gaps, and stages for achieving the international elimination target of the World Health Organization.

Corresponding author: Costin Teodor Streba, Associate Professor, MD, PhD; e-mail: costin.streba@umfcv.ro

DOI: 10.47162/RJME.61.3.02 Download PDF
Download cover
Download contents

Journal archive